STOCK TITAN
  1. Home
  2. Sec-filings
  3. ACHV
  4. [Form 4] ACHIEVE LIFE SCIENCES, INC. Insider Trading Activity

Achieve Life (ACHV) director receives 47,250 options at $5.24 strike

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

ACHIEVE LIFE SCIENCES, INC. reported that director Jeffrey S. Farrow received a grant of stock options. The award covers 47,250 shares of common stock at an exercise price of $5.24 per share, expiring on May 29, 2036. Following the grant, he holds options for 47,250 underlying shares. The options will vest in substantially equal monthly installments over 36 months starting May 29, 2026, as long as he continues providing services to the company on each vesting date.

Positive

  • None.

Negative

  • None.
Insider Farrow Jeffrey S
Role null
Type Security Shares Price Value
Grant/Award Stock Option (right to buy) 47,250 $0.00 --
Holdings After Transaction: Stock Option (right to buy) — 47,250 shares (Direct, null)
Footnotes (1)
  1. [object Object]
Options granted 47,250 options Grant to Jeffrey S. Farrow on May 29, 2026
Exercise price $5.24 per share Stock option exercise price for ACHV common stock
Underlying shares 47,250 shares Common stock underlying the option award
Expiration date May 29, 2036 Option term for Jeffrey S. Farrow’s grant
Vesting period 36 months Monthly vesting starting May 29, 2026
Post-grant option holdings 47,250 options Total options held following this transaction
Stock Option (right to buy) financial
"Security title is listed as "Stock Option (right to buy)" for the grant."
Common Stock financial
"The underlying security title for the option award is Common Stock."
Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.
exercise price financial
"The options carry an exercise price of $5.24 per share."
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
vesting financial
"The option will vest in substantially equal monthly installments over 36 months."
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
expiration date financial
"The option has an expiration date of May 29, 2036."
The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Form 4 Insider Transactions: What Each Field Means →
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Farrow Jeffrey S
(Last)(First)(Middle)
22722 29TH DR. SE
SUITE 100
(Street)
BOTHELL WASHINGTON 98021
(City)(State)(Zip)
UNITED STATES
(Country)		2. Issuer Name and Ticker or Trading Symbol
ACHIEVE LIFE SCIENCES, INC. [ ACHV ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
05/29/2026		6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Stock Option (right to buy)$5.2405/29/2026A47,250 (1)05/29/2036Common Stock47,250$047,250D
Explanation of Responses:
1. The option will vest in substantially equal monthly installments over 36 months commencing May 29, 2026, subject to the Reporting Person's provision of service to the Issuer on each vesting date.
Sandra Thomson as attorney-in-fact for Jeffrey S. Farrow06/02/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What insider transaction did ACHV report for Jeffrey S. Farrow on this Form 4?

ACHIEVE LIFE SCIENCES, INC. reported that director Jeffrey S. Farrow received a stock option grant. The award covers 47,250 shares of common stock as options, rather than an open-market purchase or sale of existing shares.

How many ACHV shares are covered by Jeffrey S. Farrow’s new stock options?

The new option grant to Jeffrey S. Farrow covers 47,250 underlying shares of ACHIEVE LIFE SCIENCES, INC. common stock. These options represent a potential future equity stake if exercised under the specified terms and vesting schedule.

What is the exercise price and expiration date of Jeffrey S. Farrow’s ACHV options?

Jeffrey S. Farrow’s options have an exercise price of $5.24 per share and expire on May 29, 2036. This means he can purchase ACHV common stock at $5.24, once vested, any time before the stated expiration date.

How do Jeffrey S. Farrow’s ACHV options vest over time?

The options will vest in substantially equal monthly installments over 36 months beginning May 29, 2026. Vesting is conditioned on Jeffrey S. Farrow continuing to provide service to ACHIEVE LIFE SCIENCES, INC. on each applicable vesting date during that three-year period.

Does the ACHV Form 4 show any open-market buying or selling by Jeffrey S. Farrow?

The Form 4 reports a grant of stock options coded as a grant, award, or other acquisition. It does not show any open-market purchases or sales of ACHIEVE LIFE SCIENCES, INC. common stock by Jeffrey S. Farrow in this specific filing.

What is Jeffrey S. Farrow’s ACHV option position after this reported grant?

After the reported grant, Jeffrey S. Farrow holds stock options covering 47,250 underlying shares of ACHIEVE LIFE SCIENCES, INC. common stock. This reflects his derivative position from this award as shown in the Form 4 data provided.